We further analyzed the protein expression of NPM1 and FBL in the TMAs of different Gleason score PCa specimens, ranging from Gleason score 6 to 10, using IHC with antibodies against NPM1 and FBL. The gene discussed is FBL; the disease is posterior cortical atrophy.